PINCELL
Innovation in dermatology
We target novel pathological pathways to develop first in class anti-inflammatory therapy for the treatment of skin diseases with high unmet medical need.
About us
PinCell is a pre-clinical stage biotech company focused on the development of new treatments for different dermatological diseases.
Therapeutic focus
PinCell research is focused on different dermatological disorders,
particularly “orphan diseases” of the skin.
Management
Antonino Amato
CEO
Carlo Pincelli
CMO, Co-Founder, Co-Inventor
Roberta Lotti
Project Manager & Senior Researcher
Brydon Bennett
CSO